pcDNA3.1/Myc-His(-)-HSulf-2 Citations (5)

Originally described in: Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans.
Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S, Rosen SD J Biol Chem. 2002 Dec 20. 277(51):49175-85. PubMed Journal

---

Articles Citing pcDNA3.1/Myc-His(-)-HSulf-2

Articles
MYCN-dependent expression of sulfatase-2 regulates neuroblastoma cell survival. Solari V, Borriello L, Turcatel G, Shimada H, Sposto R, Fernandez GE, Asgharzadeh S, Yates EA, Turnbull JE, DeClerck YA. Cancer Res. 2014 Nov 1;74(21):5999-6009. doi: 10.1158/0008-5472.CAN-13-2513. Epub 2014 Aug 27. PubMed
Enhanced tumorigenic potential of colorectal cancer cells by extracellular sulfatases. Vicente CM, Lima MA, Yates EA, Nader HB, Toma L. Mol Cancer Res. 2015 Mar;13(3):510-23. doi: 10.1158/1541-7786.MCR-14-0372. Epub 2014 Dec 4. PubMed
SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells. Vicente CM, Lima MA, Nader HB, Toma L. J Exp Clin Cancer Res. 2015 Mar 14;34:25. doi: 10.1186/s13046-015-0141-x. PubMed
Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs). Rauch JN, Chen JJ, Sorum AW, Miller GM, Sharf T, See SK, Hsieh-Wilson LC, Kampmann M, Kosik KS. Sci Rep. 2018 Apr 23;8(1):6382. doi: 10.1038/s41598-018-24904-z. PubMed
A 6-O-endosulfatase activity assay based on synthetic heparan sulfate oligomers. Benicky J, Sanda M, Panigrahi A, Liu J, Wang Z, Pagadala V, Su G, Goldman R. Glycobiology. 2023 Jun 3;33(5):384-395. doi: 10.1093/glycob/cwad026. PubMed

If you have published an article using this material, please email us at to have your article added to this page.